Mindfulness After Stroke

Sponsor
University of Southern California (Other)
Overall Status
Recruiting
CT.gov ID
NCT04553679
Collaborator
(none)
20
1
6
3.3

Study Details

Study Description

Brief Summary

The purpose of this study is to test the relevance, satisfaction and ease-of-use of an online mindfulness intervention among stroke survivors and their caregivers. Quality of life, depression, anxiety, stress and sleep quality will be assessed before, after and at 1 month after the intervention. After the intervention, participants' feedback about the usability and the satisfaction with the intervention and the online program will be gathered. Based on participants' feedback, changes to the intervention will be made to obtain a final version.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness online intervention

Detailed Description

The incidence of depression and anxiety is much higher in stroke survivors and their caregivers compared to age-matched peers. Previous work suggests that mindfulness delivered in an online format is promising for both individuals with neurological disorders and caregivers to improve quality of life and psychological well-being.

The overall objective of this project is to develop and refine an online mindfulness program that is perceived as relevant and user-friendly for stroke survivors and their caregivers. This project also aims to determine the potential impact of the mindfulness program on psychological well-being for stroke survivors and caregivers to guide the development of a future intervention study.

The process of development of the online mindfulness program will be iterative and will involve three phases: one development phase, one usability testing phase with end-users and one refinement phase.

Phase 1) The 3-week online mindfulness program will be adapted from the program developed for individuals with amyotrophic lateral sclerosis by mindfulness and stroke experts to ensure suitability and relevance for individuals with stroke.

Phase 2) A testing phase will be conducted remotely for both technical and clinical verification with 5-10 stroke survivors and 5-10 caregivers. Self-reported questionnaires about psychological well-being will be administered prior to and after the participation to the program and at a 1-month follow-up. After the program, a usability questionnaire and a semi-structured interview will be conducted to assess the usability of the mindfulness program and gather participants' feedback. For each group, differences prior to and after the mindfulness program will be assessed using a repeated measure analysis of variance. The transcribed verbatim of the semi-structured interview will be analyzed independently using thematic content analysis by 2 members of the research team.

Phase 3) Based on the results from Phase 2, modifications will be made to the online mindfulness program. If warranted, the testing phase will be replicated with a second cohort of participants.

This project will lead to the development of an online mindfulness program suitable for stroke survivors and their caregivers to improve quality of life and psychological well-being. This project will help guide the development of a planned intervention study.

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Development of an Online Mindfulness Program for Stroke Survivors and Their Caregivers
Anticipated Study Start Date :
Oct 1, 2020
Anticipated Primary Completion Date :
Mar 1, 2021
Anticipated Study Completion Date :
Apr 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Change in Stroke Impact Scale [from baseline to 3 weeks]

    Quality of life and impact of stroke after the intervention. The SIS is a 59-item measure and is divided in 8 domains. Scores range from 0-100 (with higher score showing better quality of life and lower stroke impact).

Secondary Outcome Measures

  1. Change in Hospital Anxiety and Depression Scale [from baseline to 3 weeks]

    Anxiety and depression with scores ranging from 0 (no depression/anxiety) to 21 (severe depressive/anxious symptoms)

  2. Change in NIH Perceived Stress Survey [from baseline to 3 weeks]

    10-item self-reported measure assessing perceived stress. Scores range from 10 to 50, with higher scores indicating greater levels of perceived stress.

  3. Change in Single-Item Sleep Quality Scale [from baseline to 3 weeks]

    1-item sleep quality scale ranging from 1 to 10. Higher scores indicate better sleep quality.

  4. Change in World Health Organization Quality of Life-BREF [from baseline to 3 weeks]

    Quality of life is assessed in 4 domains. Higher scores denote higher quality of life.

  5. Post-Study System Usability Questionnaire [3 weeks]

    10-item scale assessing the usability of the online mindfulness program. Higher scores indicate lower usability.

  6. Change in Zarit Burden Interview [from baseline to 3 weeks]

    Caregiver burden. Scores range from 0-88 with higher scores indicating greater burden.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of stroke (for stroke survivors) or caregiver of someone who have had a stroke

  • Ability to access Internet using a computer, a tablet and/or a smartphone

  • Ability to provide informed consent

  • Fluent in English

Exclusion Criteria:
  • Severe language impairments

  • Regular meditation or participation in a mindfulness program in the past 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Southern California Los Angeles California United States 90089

Sponsors and Collaborators

  • University of Southern California

Investigators

  • Principal Investigator: Carolee Winstein, PhD, University of Southern California

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carolee Winstein, Professor, University of Southern California
ClinicalTrials.gov Identifier:
NCT04553679
Other Study ID Numbers:
  • UP-20-00568
First Posted:
Sep 17, 2020
Last Update Posted:
Sep 17, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Carolee Winstein, Professor, University of Southern California
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 17, 2020